Overall LFST gets a fundamental rating of 3 out of 10. We evaluated LFST against 102 industry peers in the Health Care Providers & Services industry. LFST scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. LFST is valied quite expensively at the moment, while it does show a decent growth rate.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

LFST had negative earnings in the past year.
In the past year LFST had a positive cash flow from operations.
In the past 5 years LFST always reported negative net income.
In multiple years LFST reported negative operating cash flow during the last 5 years.

1.2 Ratios

LFST has a Return On Assets (-0.42%) which is comparable to the rest of the industry.
The Return On Equity of LFST (-0.61%) is comparable to the rest of the industry.
With a Return On Invested Capital value of 0.29%, LFST is not doing good in the industry: 60.78% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
ROA	-0.42%
ROE	-0.61%
ROIC	0.29%

ROA(3y)-7.15%

ROA(5y)-11.83%

ROE(3y)-10.4%

ROE(5y)-16.72%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

LFST's Operating Margin of 0.52% is in line compared to the rest of the industry. LFST outperforms 40.20% of its industry peers.
LFST does not have Profit Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	0.52%
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so LFST is destroying value.
The number of shares outstanding for LFST has been increased compared to 1 year ago.
Compared to 5 years ago, LFST has more shares outstanding
Compared to 1 year ago, LFST has a worse debt to assets ratio.

2.2 Solvency

An Altman-Z score of 2.74 indicates that LFST is not a great score, but indicates only limited risk for bankruptcy at the moment.
LFST has a better Altman-Z score (2.74) than 60.78% of its industry peers.
The Debt to FCF ratio of LFST is 2.36, which is a good value as it means it would take LFST, 2.36 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 2.36, LFST is doing good in the industry, outperforming 77.45% of the companies in the same industry.
A Debt/Equity ratio of 0.18 indicates that LFST is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.18, LFST is in the better half of the industry, outperforming 70.59% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.18
Debt/FCF	2.36
Altman-Z	2.74

ROIC/WACC0.03

WACC9.07%

2.3 Liquidity

A Current Ratio of 1.58 indicates that LFST should not have too much problems paying its short term obligations.
The Current ratio of LFST (1.58) is comparable to the rest of the industry.
A Quick Ratio of 1.58 indicates that LFST should not have too much problems paying its short term obligations.
The Quick ratio of LFST (1.58) is better than 62.75% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.58
Quick Ratio	1.58

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 88.46% over the past year.
Looking at the last year, LFST shows a quite strong growth in Revenue. The Revenue has grown by 13.39% in the last year.
Measured over the past years, LFST shows a very strong growth in Revenue. The Revenue has been growing by 42.55% on average per year.

EPS 1Y (TTM)88.46%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%100%

Revenue 1Y (TTM)13.39%

Revenue growth 3Y23.29%

Revenue growth 5Y42.55%

Sales Q2Q%16.34%

3.2 Future

LFST is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 46.80% yearly.
Based on estimates for the next years, LFST will show a quite strong growth in Revenue. The Revenue will grow by 13.96% on average per year.

EPS Next Y87.25%

EPS Next 2Y50.52%

EPS Next 3Y46.8%

EPS Next 5YN/A

Revenue Next Year14.65%

Revenue Next 2Y14.51%

Revenue Next 3Y14.54%

Revenue Next 5Y13.96%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

LFST reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 168.93 indicates a quite expensive valuation of LFST.
The rest of the industry has a similar Price/Forward Earnings ratio as LFST.
LFST is valuated expensively when we compare the Price/Forward Earnings ratio to 25.64, which is the current average of the S&P500 Index.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	168.93

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of LFST is on the same level as its industry peers.
LFST's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. LFST is cheaper than 61.76% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	23.39
EV/EBITDA	45.49

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as LFST's earnings are expected to grow with 46.80% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y50.52%

EPS Next 3Y46.8%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for LFST!.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

LIFESTANCE HEALTH GROUP INC

NASDAQ:LFST (2/2/2026, 8:19:32 PM)

Premarket: 7.18 0 (0%)

7.18

+0.11 (+1.56%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Providers & Services

Earnings (Last)11-06 2025-11-06/bmo

Earnings (Next)02-26 2026-02-26/amc

Inst Owners40.45%

Inst Owner Change0.41%

Ins Owners2.99%

Ins Owner Change-9.3%

Market Cap2.79B

Revenue(TTM)1.37B

Net Income(TTM)-9.12M

Analysts83.75

Price Target9.18 (27.86%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)2

Avg EPS beat(2)83.66%

Min EPS beat(2)67.32%

Max EPS beat(2)100%

EPS beat(4)4

Avg EPS beat(4)77.82%

Min EPS beat(4)43.98%

Max EPS beat(4)100%

EPS beat(8)7

Avg EPS beat(8)50.21%

EPS beat(12)9

Avg EPS beat(12)21.98%

EPS beat(16)10

Avg EPS beat(16)12.33%

Revenue beat(2)1

Avg Revenue beat(2)-0.82%

Min Revenue beat(2)-1.93%

Max Revenue beat(2)0.3%

Revenue beat(4)2

Avg Revenue beat(4)-0.46%

Min Revenue beat(4)-1.94%

Max Revenue beat(4)1.72%

Revenue beat(8)4

Avg Revenue beat(8)0.27%

Revenue beat(12)7

Avg Revenue beat(12)0.68%

Revenue beat(16)8

Avg Revenue beat(16)-0.04%

PT rev (1m)4.35%

PT rev (3m)8%

EPS NQ rev (1m)49.85%

EPS NQ rev (3m)0%

EPS NY rev (1m)0%

EPS NY rev (3m)33.33%

Revenue NQ rev (1m)-0.46%

Revenue NQ rev (3m)-0.93%

Revenue NY rev (1m)0%

Revenue NY rev (3m)0.35%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	168.93
P/S	2.04
P/FCF	23.39
P/OCF	18.51
P/B	1.87
P/tB	149.82
EV/EBITDA	45.49

EPS(TTM)-0.03

EYN/A

EPS(NY)0.04

Fwd EY0.59%

FCF(TTM)0.31

FCFY4.27%

OCF(TTM)0.39

OCFY5.4%

SpS3.52

BVpS3.84

TBVpS0.05

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-0.42%
ROE	-0.61%
ROCE	0.37%
ROIC	0.29%
ROICexc	0.33%
ROICexgc	2.32%
OM	0.52%
PM (TTM)	N/A
GM	N/A
FCFM	8.73%

ROA(3y)-7.15%

ROA(5y)-11.83%

ROE(3y)-10.4%

ROE(5y)-16.72%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score7

Asset Turnover0.64

Health

		Industry Rank	Sector Rank
Debt/Equity	0.18
Debt/FCF	2.36
Debt/EBITDA	4.27
Cap/Depr	56.29%
Cap/Sales	2.3%
Interest Coverage	0.37
Cash Conversion	239.11%
Profit Quality	N/A
Current Ratio	1.58
Quick Ratio	1.58
Altman-Z	2.74

F-Score7

WACC9.07%

ROIC/WACC0.03

Cap/Depr(3y)65.1%

Cap/Depr(5y)98.49%

Cap/Sales(3y)4.93%

Cap/Sales(5y)7.81%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)88.46%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%100%

EPS Next Y87.25%

EPS Next 2Y50.52%

EPS Next 3Y46.8%

EPS Next 5YN/A

Revenue 1Y (TTM)13.39%

Revenue growth 3Y23.29%

Revenue growth 5Y42.55%

Sales Q2Q%16.34%

Revenue Next Year14.65%

Revenue Next 2Y14.51%

Revenue Next 3Y14.54%

Revenue Next 5Y13.96%

EBIT growth 1Y111.08%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year452.13%

EBIT Next 3Y94.48%

EBIT Next 5Y67.21%

FCF growth 1Y420.43%

FCF growth 3YN/A

FCF growth 5Y99.09%

OCF growth 1Y6636.92%

OCF growth 3Y124.97%

OCF growth 5Y44.46%

LIFESTANCE HEALTH GROUP INC / LFST FAQ

What is the fundamental rating for LFST stock?

ChartMill assigns a fundamental rating of 3 / 10 to LFST.

What is the valuation status for LFST stock?

ChartMill assigns a valuation rating of 2 / 10 to LIFESTANCE HEALTH GROUP INC (LFST). This can be considered as Overvalued.

What is the profitability of LFST stock?

LIFESTANCE HEALTH GROUP INC (LFST) has a profitability rating of 1 / 10.